secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001213900-24-080508
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix announces 1-for-40 reverse stock split effective Sept 24, 2024 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1:40 ratio; outstanding shares reduced from ~30.2M to ~755,000 shares.
- Effective 12:01 a.m. ET on Sept 24, 2024; common stock continues trading under 'ONCO' with new CUSIP 68237Q104.
- Stockholders approved all proposals at Sept 5 annual meeting, including director elections and equity plan increase to 58M shares.
- Split intended to help meet Nasdaq $4.00 minimum bid price for initial listing.
- No fractional shares issued; cash payment for fractional shares based on Sept 23 closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024080508/0001213900-24-080508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024080508/ea0215232-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-080508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer